MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
|
9425228 |
1998 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma.
|
9311594 |
1997 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
|
8528263 |
1996 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
|
7652577 |
1995 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3
|
|
0.800 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
melanoma
|
|
0.740 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
melanoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
We observed no disease-related mutations in CDKN2A, but one patient had a CDK4 R24H mutation and strong family history of melanoma.
|
19238106 |
2009 |
melanoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
No disease-related CDKN2A germline mutations were identified in any of the melanoma patients analysed but the previously described CDK4 mutation, Arg24His, was found in one patient with a family history of melanoma.
|
17505264 |
2007 |
melanoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
In this article, we report that CDK4 codon 24 is mutated from CGT to CAT (Arg24His) in this unusually large melanoma kindred.
|
15880589 |
2005 |
melanoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
Dominant activating mutations affecting codon 24 of the CDK4 gene (replacement of Arg24 by Cys or His) render CDK4 insensitive to p16(INK4) inhibition and are responsible for melanoma susceptibility in some kindreds.
|
12904177 |
2003 |
Multiple Myeloma
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Adenocarcinoma of lung (disorder)
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Cutaneous Melanoma
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Multiple Myeloma
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Adenocarcinoma of lung (disorder)
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Cutaneous Melanoma
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |